LifeMD (LFMD) Competitors $9.94 -0.47 (-4.51%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$9.90 -0.04 (-0.45%) As of 08/1/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LFMD vs. PACS, LFST, ARDT, NHC, GRAL, TDOC, VRDN, AHCO, AGL, and PNTGShould you be buying LifeMD stock or one of its competitors? The main competitors of LifeMD include PACS Group (PACS), LifeStance Health Group (LFST), Ardent Health (ARDT), National HealthCare (NHC), GRAIL (GRAL), Teladoc Health (TDOC), Viridian Therapeutics (VRDN), AdaptHealth (AHCO), Agilon Health (AGL), and The Pennant Group (PNTG). These companies are all part of the "healthcare" industry. LifeMD vs. Its Competitors PACS Group LifeStance Health Group Ardent Health National HealthCare GRAIL Teladoc Health Viridian Therapeutics AdaptHealth Agilon Health The Pennant Group PACS Group (NYSE:PACS) and LifeMD (NASDAQ:LFMD) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, media sentiment, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations. Do analysts rate PACS or LFMD? PACS Group presently has a consensus target price of $34.29, indicating a potential upside of 222.84%. LifeMD has a consensus target price of $13.86, indicating a potential upside of 39.41%. Given PACS Group's higher possible upside, research analysts clearly believe PACS Group is more favorable than LifeMD.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PACS Group 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.86LifeMD 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.00 Do insiders and institutionals hold more shares of PACS or LFMD? 35.5% of LifeMD shares are held by institutional investors. 18.4% of LifeMD shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is PACS or LFMD more profitable? PACS Group has a net margin of 0.00% compared to LifeMD's net margin of -4.58%. Company Net Margins Return on Equity Return on Assets PACS GroupN/A N/A N/A LifeMD -4.58%N/A -15.19% Does the media prefer PACS or LFMD? In the previous week, PACS Group had 10 more articles in the media than LifeMD. MarketBeat recorded 13 mentions for PACS Group and 3 mentions for LifeMD. PACS Group's average media sentiment score of 0.58 beat LifeMD's score of 0.37 indicating that PACS Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PACS Group 6 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Positive LifeMD 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Which has higher earnings and valuation, PACS or LFMD? PACS Group has higher revenue and earnings than LifeMD. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPACS Group$3.11B0.52$112.87MN/AN/ALifeMD$212.45M2.13-$18.88M-$0.34-29.24 Which has more risk & volatility, PACS or LFMD? PACS Group has a beta of 0.88, indicating that its stock price is 12% less volatile than the S&P 500. Comparatively, LifeMD has a beta of 1.72, indicating that its stock price is 72% more volatile than the S&P 500. SummaryPACS Group beats LifeMD on 8 of the 14 factors compared between the two stocks. Get LifeMD News Delivered to You Automatically Sign up to receive the latest news and ratings for LFMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LFMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LFMD vs. The Competition Export to ExcelMetricLifeMDMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$451.77M$7.05B$5.53B$9.35BDividend YieldN/A2.89%4.74%4.14%P/E Ratio-29.2364.0028.9723.78Price / Sales2.1333.52444.8397.58Price / CashN/A25.5124.4827.20Price / Book-110.447.908.365.61Net Income-$18.88M$239.96M$3.25B$265.26M7 Day Performance-8.56%-4.82%-3.55%-4.34%1 Month Performance-20.77%-3.79%5.11%4.11%1 Year Performance50.83%18.57%25.34%17.92% LifeMD Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LFMDLifeMD2.4003 of 5 stars$9.94-4.5%$13.86+39.4%+50.8%$451.77M$212.45M-29.23230News CoveragePositive NewsUpcoming EarningsAnalyst DowngradePACSPACS Group3.2528 of 5 stars$11.83+1.2%$34.29+189.8%-70.0%$1.78B$3.56B0.0032,433Positive NewsUpcoming EarningsLFSTLifeStance Health Group3.1795 of 5 stars$4.17+0.7%$8.42+101.8%-32.4%$1.61B$1.25B-41.7010,218Upcoming EarningsARDTArdent Health3.7227 of 5 stars$10.67-3.5%$20.30+90.3%-41.1%$1.58B$5.97B6.5524,900Upcoming EarningsNHCNational HealthCareN/A$95.82-0.6%N/A-24.6%$1.48B$1.37B12.0112,400News CoverageGRALGRAIL1.0995 of 5 stars$38.27-5.0%$31.50-17.7%+97.6%$1.45B$125.60M-0.631,360Gap DownTDOCTeladoc Health3.4294 of 5 stars$8.18-0.2%$9.67+18.2%-12.7%$1.44B$2.55B-1.385,500Earnings ReportAnalyst RevisionVRDNViridian Therapeutics1.1761 of 5 stars$17.26-0.1%$37.56+117.6%+14.8%$1.41B$300K-4.4850Short Interest ↑AHCOAdaptHealth3.9501 of 5 stars$9.59+1.6%$13.40+39.7%-20.5%$1.27B$3.26B16.8210,500Positive NewsUpcoming EarningsAGLAgilon Health1.6216 of 5 stars$1.99-3.4%$4.71+136.9%-73.3%$852.74M$6.06B-3.371,076Upcoming EarningsPNTGThe Pennant Group3.5688 of 5 stars$23.22-0.6%$33.80+45.6%-24.6%$804.85M$695.24M30.557,000Upcoming Earnings Related Companies and Tools Related Companies PACS Group Competitors LifeStance Health Group Competitors Ardent Health Competitors National HealthCare Competitors GRAIL Competitors Teladoc Health Competitors Viridian Therapeutics Competitors AdaptHealth Competitors Agilon Health Competitors The Pennant Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LFMD) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersWall Street Laughed. Now They're Buying.For six months, I’ve been pounding the table on a major gold miner—while Twitter pundits laughed. But now, the...Golden Portfolio | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Create New Advertiser | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOut with the old (A.I.) - In with the new (E.I.)One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredStrange twist to Bitcoin’s rallyThe #1 crypto to buy today Better than Bitcoin? (top crypto for less than $1) Over the past 15 years, B...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LifeMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
